Variant report
Variant | rs609806 |
---|---|
Chromosome Location | chr19:21512949-21512950 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:21510924..21513197-chr19:21688433..21691004,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000197013 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs1114305 | 0.88[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs1875256 | 0.90[ASN][1000 genomes] |
rs2086319 | 1.00[AFR][1000 genomes];0.91[AMR][1000 genomes];0.90[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs2434996 | 0.85[AFR][1000 genomes];0.88[AMR][1000 genomes];0.87[ASN][1000 genomes] |
rs2562402 | 0.85[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs2562409 | 0.88[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs2562415 | 0.83[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs2562438 | 1.00[AFR][1000 genomes];0.91[AMR][1000 genomes];0.90[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs2650797 | 0.91[AMR][1000 genomes];0.83[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs2650798 | 1.00[AFR][1000 genomes];0.91[AMR][1000 genomes];0.83[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs2650842 | 1.00[AFR][1000 genomes];0.91[AMR][1000 genomes];0.90[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs2650849 | 0.88[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs2650851 | 0.85[AMR][1000 genomes];0.83[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs279804 | 0.83[EUR][1000 genomes] |
rs279805 | 0.83[EUR][1000 genomes] |
rs279810 | 0.83[EUR][1000 genomes] |
rs279811 | 0.83[EUR][1000 genomes] |
rs279812 | 0.83[EUR][1000 genomes] |
rs279814 | 0.82[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs279815 | 0.83[EUR][1000 genomes] |
rs279816 | 0.83[EUR][1000 genomes] |
rs279820 | 0.83[EUR][1000 genomes] |
rs28771683 | 0.83[ASN][1000 genomes] |
rs2914626 | 0.85[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs2914627 | 0.85[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs2914635 | 0.80[AMR][1000 genomes];0.83[ASN][1000 genomes] |
rs2914645 | 1.00[AFR][1000 genomes];0.91[AMR][1000 genomes];0.83[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs2928188 | 1.00[AFR][1000 genomes];0.85[AMR][1000 genomes];0.83[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs2928209 | 1.00[AFR][1000 genomes];0.91[AMR][1000 genomes];0.90[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs2928211 | 0.88[ASN][1000 genomes] |
rs2928216 | 0.83[AFR][1000 genomes];0.91[AMR][1000 genomes];0.90[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs2928218 | 1.00[AFR][1000 genomes];0.91[AMR][1000 genomes];0.90[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs2937157 | 0.91[AMR][1000 genomes];0.83[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs2937174 | 0.91[AMR][1000 genomes];0.83[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs2968022 | 1.00[AFR][1000 genomes];0.91[AMR][1000 genomes];0.90[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs2968023 | 0.91[AMR][1000 genomes];0.90[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs2968024 | 0.83[AFR][1000 genomes];0.91[AMR][1000 genomes];0.90[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs2968040 | 0.91[AMR][1000 genomes];0.89[ASN][1000 genomes] |
rs2968041 | 0.91[AMR][1000 genomes];0.83[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs2968045 | 0.91[AMR][1000 genomes];0.83[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs2968046 | 0.88[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs2968066 | 0.88[AMR][1000 genomes];0.90[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs2968082 | 0.83[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs2968086 | 1.00[AFR][1000 genomes];0.91[AMR][1000 genomes];0.90[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs472472 | 0.94[AMR][1000 genomes];0.90[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs475162 | 1.00[AFR][1000 genomes];0.97[AMR][1000 genomes];0.90[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs476376 | 0.83[EUR][1000 genomes] |
rs478046 | 0.83[EUR][1000 genomes] |
rs487991 | 0.90[EUR][1000 genomes] |
rs489613 | 1.00[AMR][1000 genomes];0.91[ASN][1000 genomes] |
rs489845 | 0.82[AMR][1000 genomes];0.90[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs492271 | 1.00[AMR][1000 genomes];0.90[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs499445 | 0.92[AFR][1000 genomes];1.00[AMR][1000 genomes];0.90[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs501563 | 0.92[AFR][1000 genomes];0.94[AMR][1000 genomes];0.90[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs504026 | 0.83[EUR][1000 genomes] |
rs508656 | 0.83[EUR][1000 genomes] |
rs511469 | 0.83[EUR][1000 genomes] |
rs516519 | 0.83[ASN][1000 genomes] |
rs527060 | 0.97[AMR][1000 genomes];0.90[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs537114 | 0.82[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs540637 | 0.82[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs540714 | 0.82[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs541639 | 0.83[EUR][1000 genomes] |
rs547516 | 0.92[AFR][1000 genomes];0.94[AMR][1000 genomes];0.90[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs555596 | 0.92[AFR][1000 genomes];1.00[AMR][1000 genomes];0.90[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs583680 | 0.83[EUR][1000 genomes] |
rs586144 | 0.86[AMR][1000 genomes];0.83[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs598959 | 0.82[AMR][1000 genomes];0.90[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs600186 | 0.94[AMR][1000 genomes];0.83[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs612877 | 0.86[AMR][1000 genomes];0.90[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs627522 | 0.89[ASN][1000 genomes] |
rs631436 | 0.92[AFR][1000 genomes];1.00[AMR][1000 genomes];0.83[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs651454 | 0.94[AMR][1000 genomes];0.90[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs661453 | 0.83[EUR][1000 genomes] |
rs8102235 | 0.85[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs8112775 | 0.90[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs924485 | 1.00[AFR][1000 genomes];0.91[AMR][1000 genomes];0.83[EUR][1000 genomes];0.91[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | esv3518033 | chr19:21278465-21747567 | Strong transcription Weak transcription ZNF genes & repeats Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 41 gene(s) | inside rSNPs | diseases |
2 | esv3518034 | chr19:21278465-21747567 | ZNF genes & repeats Weak transcription Genic enhancers Active TSS Enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 41 gene(s) | inside rSNPs | diseases |
3 | esv3414204 | chr19:21301761-21839451 | ZNF genes & repeats Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Strong transcription Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 44 gene(s) | inside rSNPs | diseases |
4 | nsv911416 | chr19:21388995-21548211 | Flanking Active TSS Weak transcription Strong transcription ZNF genes & repeats Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 12 gene(s) | inside rSNPs | diseases |
5 | nsv911417 | chr19:21388995-21564001 | Weak transcription Strong transcription Active TSS ZNF genes & repeats Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 13 gene(s) | inside rSNPs | diseases |
6 | esv3325271 | chr19:21445407-21792817 | Weak transcription ZNF genes & repeats Active TSS Flanking Active TSS Strong transcription Genic enhancers Enhancers Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 35 gene(s) | inside rSNPs | diseases |
7 | nsv911420 | chr19:21454672-21613397 | ZNF genes & repeats Strong transcription Active TSS Weak transcription Enhancers Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 15 gene(s) | inside rSNPs | diseases |
8 | esv2751783 | chr19:21465822-21726337 | Strong transcription ZNF genes & repeats Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 31 gene(s) | inside rSNPs | diseases |
9 | esv3363678 | chr19:21483148-21756908 | Strong transcription Active TSS ZNF genes & repeats Weak transcription Flanking Active TSS Genic enhancers Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 31 gene(s) | inside rSNPs | diseases |
10 | nsv963023 | chr19:21491992-21570395 | Weak transcription ZNF genes & repeats Enhancers Flanking Active TSS Strong transcription Active TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
11 | esv3415719 | chr19:21511760-21519079 | Flanking Active TSS Enhancers Active TSS Weak transcription ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive region | 3 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:21512400-21513200 | Flanking Active TSS | Dnd41 | blood |
2 | chr19:21512400-21513600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr19:21512400-21513600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr19:21512400-21515000 | Weak transcription | H9 Cell Line | embryonic stem cell |
5 | chr19:21512600-21513000 | Enhancers | Primary B cells from cord blood | blood |
6 | chr19:21512600-21513000 | Enhancers | Primary B cells from peripheral blood | blood |
7 | chr19:21512600-21513000 | Enhancers | Primary T cells fromperipheralblood | blood |
8 | chr19:21512600-21513000 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
9 | chr19:21512600-21513000 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
10 | chr19:21512600-21513000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
11 | chr19:21512600-21513200 | Enhancers | Primary T helper cells fromperipheralblood | blood |